Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

MAb 1DT3-D disclosed for treatment of B-cell lymphoma

Oct. 25, 1996

HER2/neu peptide fragment provokes immune response against tumor cells

Oct. 18, 1996

Ovarian cancer vaccine enters phase II/III trials

Oct. 11, 1996

Patent coverage for The Immune Response Corporation's colon cancer vaccine

Oct. 11, 1996

Chemokine polypeptide from Human Genome Sciences has multiple potential uses

Oct. 11, 1996

Combination therapy Maxamine/IL-2 effective in extending remission time & preventing relapse

Oct. 4, 1996

Progenics cancer vaccine enters clinical trials

Oct. 4, 1996

Novopharm develops new recombinant form of MAb

Oct. 4, 1996

Cel-Sci's Multikine to be tested clinically at additional centers

Sep. 27, 1996

IL-2 receptor-binding polypeptide described by Boehringer Ingelheim

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...